Coloplast traded at 410.00 this Friday April 24th, decreasing 10.30 or 2.45 percent since the previous trading session. Looking back, over the last four weeks, Coloplast lost 5.33 percent. Over the last 12 months, its price fell by 43.46 percent. Looking ahead, we forecast Coloplast to be priced at 426.61 by the end of this quarter and at 367.16 in one year, according to Trading Economics global macro models projections and analysts expectations.
Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.